Lindsey M. Hoffman - Concepedia

Author

Lindsey M. Hoffman

Also Known As

C. Eberhart, J A Robertson, J. Leach, Jensen, Nikolaj K G, L Hoffman, L. Hoffman, L. M. Hoffman, L.M. Hoffman, Lindsey M. Hoffman, Lindsey Hoffman

200

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Children's Hospital Colorado Cincinnati Children's Hospital Medical Center Hospital for Sick Children Morgan Adams Foundation

About

Lindsey M. Hoffman is an author at University of Colorado Denver specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	2.7K
2	Health Sciences	5	5	507
3	Public Health	2	2	38
4	Engineering	1	1	251
5	Biomedical Engineering	1	1	21

Lindsey M. Hoffman

Publications

Citations

H-Index

Page 1

	Year	Citations
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Kristian W. Pajtler, Hendrik Witt, Martin Sill, Cancer Cell Neuro-oncologyTumor BiologyTumoral PathologyTumor InnervationMedicine	2015	1.2K
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz, Journal of Clinical Oncology Pediatric Brain TumorsOncologic ImagingHigh-grade GliomasGliomaLong-term Survivors	2018	408
Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types Andrea M. Griesinger, Diane K. Birks, Andrew M. Donson, The Journal of Immunology	2013	252
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors Jonathon Torchia, Brian Golbourn, Shengrui Feng, Cancer Cell Tumor BiologyRadiation OncologyNeuro-oncologyOncologyEngineering	2016	251
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics Lindsey M. Hoffman, Mariko DeWire, Scott Ryall, Acta Neuropathologica Communications	2016	195
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency Anirban Das, Sumedha Sudhaman, Daniel A. Morgenstern, Nature Medicine	2022	132
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study Bryan Li, Alexandre Vasiljevic, Christelle Dufour, Acta Neuropathologica Neuro-oncologyTumoral PathologyMolecular Sub-groupsPathologyNeuropathology	2019	106
Pediatric Low-Grade Ganglioglioma Roy Dudley, Michelle Torok, Danielle Gallegos, Neurosurgery	2015	101
Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma Sydney Grob, David M. Mirsky, Andrew M. Donson, Frontiers in Oncology	2019	88
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor Patrick Sin‐Chan, Iqra Mumal, Tannu Suwal, Cancer Cell GliomaOncogenic AgentMedicineHijacked Super-enhancersDistinct Therapeutic Vulnerability	2019	83

Page 1